Evidence map›Paper›PMID 40899568›Full record

Observational studyAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Integrin αvβ6-Targeted PET/CT Imaging of Non-Small Cell Lung Cancer with [

Huiqin Wu, Chongjiao Li, Ling Li, Yueli Tian, Zhiwei Xiao, Yiwei Huang, Juan Zhong, Jianying Huang, Qiongrong Chen, Yong He

Abstract readObservational Study
In one paragraph

Observational study in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. [European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Article
  5. Integrin αvβ6-Targeted PET/CT Imaging of Non-Small Cell Lung Cancer with [Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Huiqin WuDepartment of Nuclear Medicine, Zhongnan Hospital of Wuhan University, No. 169 East Lake Road, Wuchang District, Wuhan, Hubei Province, 430071, China.ORCID https://orcid.org/0009-0002-4473-6936
Chongjiao LiDepartment of Nuclear Medicine, Zhongnan Hospital of Wuhan University, No. 169 East Lake Road, Wuchang District, Wuhan, Hubei Province, 430071, China.
Ling LiDepartment of Nuclear Medicine, Zhongnan Hospital of Wuhan University, No. 169 East Lake Road, Wuchang District, Wuhan, Hubei Province, 430071, China.
Yueli TianDepartment of Nuclear Medicine, Zhongnan Hospital of Wuhan University, No. 169 East Lake Road, Wuchang District, Wuhan, Hubei Province, 430071, China.
Zhiwei XiaoDepartment of Nuclear Medicine, Zhongnan Hospital of Wuhan University, No. 169 East Lake Road, Wuchang District, Wuhan, Hubei Province, 430071, China.
Yiwei HuangDepartment of Nuclear Medicine, Zhongnan Hospital of Wuhan University, No. 169 East Lake Road, Wuchang District, Wuhan, Hubei Province, 430071, China.
Juan ZhongDepartment of Nuclear Medicine, Zhongnan Hospital of Wuhan University, No. 169 East Lake Road, Wuchang District, Wuhan, Hubei Province, 430071, China.
Jianying HuangClinical Trial Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Qiongrong ChenDepartment of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Yong HeDepartment of Nuclear Medicine, Zhongnan Hospital of Wuhan University, No. 169 East Lake Road, Wuchang District, Wuhan, Hubei Province, 430071, China.ORCID https://orcid.org/0000-0002-9846-7578

Funding

Hubei Key Laboratory of Molecular Imaging Open Fund General Project 2022019Hubei Province Health and Family Planning Scientific Research Project WJ2023M051National Natural Science Foundation of China 82171986National Natural Science Foundation of China 82301789National Natural Science Foundation of China 82372005National Natural Science Foundation of China 82572274Transformation Project of Scientific and Technological Achievements of Zhongnan Hospital of Wuhan University 202204KJCGZHTranslational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University ZNJC202209
6 · The paper itself

Abstract

Integrin αvβ6, an epithelial-specific integrin, plays a crucial role in the development and prognosis of multiple tumors and has emerged as a potential target for cancer diagnosis and treatment. The novel integrin αvβ6-targeted radiotracer [

Indexed as

Antigens, NeoplasmCarcinoma, Non-Small-Cell LungIntegrinsLung NeoplasmsPositron Emission Tomography Computed TomographyAdultAgedFemaleGallium RadioisotopesHumansImmunohistochemistryLymphatic MetastasisLymph NodesMaleMiddle AgedNeoplasm StagingAntigens, NeoplasmGallium-68Gallium Radioisotopesintegrin alphavbeta6Integrins[18F]FDG[68Ga]Ga‐Trivehexinintegrin αvβ6non‐small cell lung cancerPET/CT

Identifiers

PMID40899568
PMCPMC12667533

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.